Qiming Venture Partners
China healthcare AI start-up Huimei gets $41m Series D
Eastern Bell Capital has led a Series D round of more than CNY 300m (USD 41m) for Huimei Cloud Technology, a China-based provider of artificial intelligence-enabled (AI) software that helps doctors make clinical decisions.
Qiming, Orbimed lead Series A for China's Epigenic
Qiming Venture Partners and OrbiMed Asia Partners have led a USD 32m Series A round for Chinese gene editing therapy start-up Epigenic Therapeutics.
China's PE-backed Ubtech Robotics files for HK IPO
Ubtech Robotics, a China-based developer of service and humanoid robots valued at CNY 32bn (USD 4.4bn) in its most recent private funding round, has filed for a Hong Kong IPO.
China's Qiming joins round for blockchain privacy developer
China's Qiming Venture Partners has participated in a USD 25m Series A for P0x Labs, the developer behind blockchain-based privacy services provider Manta Network.
China’s Qiming appoints Qualcomm investor as venture partner
Qiming Venture Partners has appointed James Shen, previously a managing partner at Qualcomm Ventures, as a venture partner.
China’s Cornerstone Robotics raises $112m
China-based Cornerstone Robotics, a surgical robots specialist, has raised a CNY 800m (USD 112m) round featuring BridgeOne Capital and Lenovo Capital & Incubator Group.
LP interview: Dietrich Foundation
The Dietrich Foundation, which has one of the highest China PE and VC allocations of any US LP, is cautious on the market but not disengaged. Meanwhile, India and Southeast Asia are becoming more interesting
Qiming hits $930m final close on latest renminbi fund
Qiming Venture Partners has closed its seventh renminbi-denominated fund on CNY 6.5bn (USD 930m), marking what it claims is China's largest local currency fundraise of 2023 to date
Deal focus: Qiming bets on resilience in China’s coffee space
Qiming Venture Partners has doubled down on Chinese coffee brand Tasogare, identifying a consumer category endowed with rare advantages and poised to benefit from a broader domestic retail rebound
Japan-inspired Chinese coffee brand gets Series C
Chinese coffee brand Tasogare has raised several hundred million renminbi in a Series C funding round led by Yijing Capital and state-controlled Jiande Group. Qiming Venture Partners and Bu’er Capital re-upped.
China autonomous truck developer DeepWay raises $112m
China’s DeepWay, a smart electric truck developer established by Baidu, has raised CNY 770m (USD 112m) in an extended Series A round featuring SB China Venture Capital (SBCVC).
Fund finance: Filling Asia’s SVB void
Silicon Valley Bank’s collapse has prompted Asia-based GPs to review their relationships with lenders, for fund finance and general banking. Smaller managers may find the process challenging
Qiming, Ince invest in China, US biotech start-up
Qiming Venture Partners and Ince Capital have led a USD 50m Series B round for China and US-based oncology and autoimmune diseases treatments developer Allorion Therapeutics.
China semiconductor packaging player gets Series B extension
Chinese semiconductor packaging specialist Jiangsu Jing Chuang Advanced (JCA) Electronic Technology has raised a Series B extension of several hundreds of million renminbi led by Qiming Venture Partners.
Deal focus: Qiming backs Chinese GPT pioneer
Frontis.ai is a Chinese start-up founded by local entrepreneur who helped lay the groundwork for ChatGPT in the US. Qiming Venture Partners was won over by its product conception capabilities
Qiming, Matrix back Chinese AI start-up Frontis
Chinese artificial intelligence generated content (AIGC) start-up Frontis.ai has raised a round of hundreds of millions of renminbi led by Qiming Venture Partners with support from Matrix Partners China.
China's Oricell secures $45m Series B extension
Qatar Investment Authority (QIA) and RTW Investments, a US-based healthcare investor, have led a Series B extension of USD 45m for Oricell Therapeutics, a China-based drug developer working on CAR-T cell therapies.
AVCJ Awards 2022: Fundraising of the Year – Venture Capital: Qiming Venture Partners
Qiming Venture Partners defied tough conditions to close its eighth US dollar-denominated fund on USD 2.5bn. Managing Partner Nisa Leung looks back on the process and examines the prospects for healthcare
Hesai gains 11% on debut after $190m US offering
Hesai Technology, a China-based developer of sensors used in autonomous driving, traded up on debut after completing the largest US IPO by a Chinese company since Didi in 2021.
China's Structure Therapeutics soars on US debut
Structure Therapeutics, a China and US-based drug developer specialising in novel oral therapeutics, performed strongly on its trading debut following an upsized USD 161.1m NASDAQ IPO.
China adult online education platform raises $41m in US IPO
QuantaSing Group, a Chinese adult tuition platform that spun out from wealth management and investment education business Erwan Technology, has traded relatively flat following a USD 41m IPO on NASDAQ.